Molecular Modeling Study on the Interaction Mechanism between the LRRK2 G2019S Mutant and Type I Inhibitors by Integrating Molecular Dynamics Simulation, Binding Free Energy Calcul by Shuoyan Tan Qianqian Zhang Jun Wang Peng Gao Guotong Xie Huanxiang Liu and Xiaojun Yao

Molecular Modeling Study on the Interaction Mechanism between the LRRK2 G2019S Mutant and Type I Inhibitors by Integrating Molecular Dynamics Simulation, Binding Free Energy Calcul by Shuoyan Tan Qianqian Zhang Jun Wang Peng Gao Guotong Xie Huanxiang Liu and Xiaojun Yao

Author:Shuoyan Tan, Qianqian Zhang, Jun Wang, Peng Gao, Guotong Xie, Huanxiang Liu, and Xiaojun Yao
Format: pdf
Tags: ACS Chem. Neurosci. 2022.13:599-612, Parkinson’s disease, leucine-rich repeat kinase 2 (LRRK2), inhibitor, molecular dynamics (MD) simulation, MM-GBSA, pharmacophore modeling
Published: 2022-02-22T12:11:04+00:00


Download



Copyright Disclaimer:
This site does not store any files on its server. We only index and link to content provided by other sites. Please contact the content providers to delete copyright contents if any and email us, we'll remove relevant links or contents immediately.